USFDA Issues Form 483 to Gland Pharma's Visakhapatnam Unit
February 25, 2025 16:48
USFDA issued a Form 483 with three observations to Gland Pharma's facility in Visakhapatnam after a pre-approval inspection for sterile APIs. The observations are procedural in nature and will be...